| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | SVP, Research And Development
1 company
Glenn Gregory M is a President, R&D at NOVAVAX INC. Recent SEC Form 4 filings include 5 buys and 2 sells.
Estimated insider holdings value: $130K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2016 | NVAX Novavax Inc | President, R&D | Buy | 1,000 | $1.45 | $1,446.00 | +29.2% | |
| Sep 21, 2016 | NVAX Novavax Inc | President, R&D | Buy | 1,000 | $1.65 | $1,649.00 | +41.2% | |
| Jan 31, 2016 | NVAX Novavax Inc | SVP, Research And Development | Buy | 2,369 | $4.38 | $10,376.22 | +4,084% | |
| Dec 16, 2015 | NVAX Novavax Inc | SVP, Research And Development | Sale+OE | 61,886 | $8.58 | $530,697.20 | -99.9% | |
| Aug 18, 2015 | NVAX Novavax Inc | SVP, Research And Development | Sale+OE | 15,000 | $13.52 | $202,743.00 | -92.8% | |
| Jul 31, 2015 | NVAX Novavax Inc | SVP, Research And Development | Buy | 892 | $2.28 | $2,033.76 | +335.3% | |
| Jan 31, 2015 | NVAX Novavax Inc | SVP, Research And Development | Buy | 866 | $2.28 | $1,974.48 | New |